Cargando…
The magic of small-molecule drugs during ex vivo expansion in adoptive cell therapy
In the past decades, advances in the use of adoptive cellular therapy to treat cancer have led to unprecedented responses in patients with relapsed/refractory or late-stage malignancies. However, cellular exhaustion and senescence limit the efficacy of FDA-approved T-cell therapies in patients with...
Autores principales: | Zhang, Hanwen, Passang, Tenzin, Ravindranathan, Sruthi, Bommireddy, Ramireddy, Jajja, Mohammad Raheel, Yang, Lily, Selvaraj, Periasamy, Paulos, Chrystal M., Waller, Edmund K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160370/ https://www.ncbi.nlm.nih.gov/pubmed/37153607 http://dx.doi.org/10.3389/fimmu.2023.1154566 |
Ejemplares similares
-
Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expression
por: Zhu, Jingru, et al.
Publicado: (2022) -
Dendritic Cells Pulsed with Cytokine-Adjuvanted Tumor Membrane Vesicles Inhibit Tumor Growth in HER2-Positive and Triple Negative Breast Cancer Models
por: Munoz, Luis E., et al.
Publicado: (2021) -
Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma
por: Ravindranathan, Sruthi, et al.
Publicado: (2022) -
Optimization of Culture Media for Ex vivo T-Cell Expansion for Adoptive T-Cell Therapy
por: Rahimmanesh, Ilnaz, et al.
Publicado: (2022) -
Expression of tdTomato and luciferase in a murine lung cancer alters the growth and immune microenvironment of the tumor
por: Huang, Lei, et al.
Publicado: (2021)